Document:

TH's EA 01/23/06

    

      January
        23, 2006

      

      Terrell
        Herring

      

      

      
        	 	
                Re:

              	
                Amendment
                  to Employment Agreement

              

      

      

      Dear
        Terrell:

      

      This
        letter confirms our agreement and shall serve to amend the April 8, 2002
        Employment Agreement between you and the Company in accordance with the
        following:

      

      	a.  	
              Fringe
                Benefits

            

       

      A
        sentence shall be added at the end of Paragraph 3 (b) to
        read
        as follows:

      

       

      In
        addition to the benefits described above, the Company shall provide life
        insurance to the Executive in a minimum amount of $1,000,000.

       

      	b.  	
              Bonus

            

       

      Paragraph
        3 (c) shall
        be
        amended to read as follows:

      

       

      The
        Executive shall be eligible for a bonus in each calendar year, based on the
        Executive’s success in reaching or exceeding performance objectives as
        determined by the Chief Executive Officer or his/her designee, the amount
        of
        such bonus, if any, to be determined in the discretion of the Company.
        Notwithstanding the foregoing, if the Executive remains employed by the Company
        through the bonus payout date, the Executive shall be entitled to a bonus
        range
        of 0 - 100% (50% target) of the Executive’s then current base salary, with the
        amount of such bonus, if any, remaining subject to the discretion of the
        Company. 

       

      If
        the
        Executive remains employed through December 31, 2006, the Executive will
        be
        guaranteed a minimum bonus payout of $100,000. 

       

      c. Additional
        Pay

      

      Paragraph
        3 (g) shall
        be
        amended to read as follows:

       

      If
        there
        is a Change in Control (as defined in paragraph 5(f) herein), and the Executive
        is employed by the Company upon the Change in Control, and, in the sole judgment
        and discretion of the Company, the Executive has satisfactorily performed
        all
        assigned duties, including using his best efforts to facilitate a Change
        in
        Control, the Company shall award the Executive up to eighteen (18) months
        base
        pay, minus such deductions as may be required by law or reasonably requested
        by
        the Executive. The payment provided for in this paragraph 3(g) shall be payable
        in two equal installments, the first installment of nine (9) months shall
        be
        paid to the Executive within thirty (30) days following the Change in Control,
        and the second installment of nine (9) months shall be paid to the Executive
        on
        the earlier of (i) the six (6) month anniversary of the Change in Control
        or
        (ii) upon the termination Without Cause of the Executive’s employment by the
        Company; provided however, that no second installment payment shall be made
        hereunder if the Executive’s employment with the surviving or resulting entity
        is terminated for any reason or than by the Company Without Cause. If the
        Executive’s employment hereunder is terminated Without Cause within the two
        months immediately preceding the Change in Control, the Executive shall be
        entitled to eighteen (18) months base pay pursuant to this paragraph 3(g),
        minus
        such deductions as may be required by law or reasonably requested by the
        Executive, and any payment to which the Executive may be entitled pursuant
        to
        paragraph 6 (c) of this Agreement; provided however, that no payment shall
        be
        made hereunder if the Executive’s employment is terminated for any reason other
        than Without Cause or if, in the sole judgment and discretion of the Company,
        The Executive fails to satisfactorily perform all assigned duties, including
        using his best efforts to facilitate a Change in Control. The Executive
        acknowledges that the payments provided for in this paragraph 3(g) are in
        lieu
        of (and not in addition to) any other payments or benefits to which the
        Executive might otherwise be entitled due to a change in control, including
        but
        not limited to, any stay bonuses, severance payments or termination benefits
        of
        any kind offered to employees in connection with a change in control, whether
        pursuant to a plan, arrangement, policy or otherwise; provided however, that
        nothing herein shall effect the Executive’s right to payment pursuant to
        paragraph 6 (c ) of this agreement.

       

      

       

      d. 
        Termination Without Cause or for Good Reason

       

      Paragraph
        6 (c) shall
        be
        amended to read as follows:

       

      If
        the
        Executive's employment hereunder is terminated by the Company Without Cause
        pursuant to Section 5(a)(iv) above or For Good Reason pursuant to Section
        5
        (a)(v) the Company shall award the Executive severance benefits, subject
        to the
        terms and conditions of this Agreement and of The Ventiv Health, Inc. Severance
        Benefit Plan, if applicable. A lump sum payment of fifty two (52) weeks of
        the
        Executive’s base pay, minus such deductions as may be required by law or
        reasonably requested by the Executive to be paid out immediately. If Executive
        has not secured a new position with a competitive company in the Pharma Services
        arena, the Executive will receive an additional twenty six (26) weeks of
        Executive’s base pay; paid bi-weekly, minus such deductions as may be required
        by law or reasonably requested by the Executive. In order to be eligible
        to
        receive any Severance Payment pursuant to this paragraph 6, the Executive
        must
        sign, prior to receiving such Severance Payment, a valid release and waiver
        of
        all claims against the Company relating to the executive’s employment or the
        termination thereof, in a format to be determined by the Company. No payment
        shall be made hereunder until at least eight (8) days following the execution
        and delivery by the Executive of the valid release and waiver.

       

      

       

      e.
         Continuing Effectiveness
        of Employment Agreement

       

      Except
        as
        modified herein, the Employment Agreement dated April 8, 2002, shall remain
        in
        full force and effect in accordance with their respective terms. 

       

      

       

      	f.  	
              Notice
                of Resignation

            

       

      The
        Executive shall give the Company three (3) months notice prior to any
        resignation with the exception of resignation for Good Reason as defined
        in
        paragraph 5(e).

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

       

      If
        the
        foregoing is satisfactory, please so indicate by signing and returning to
        me the
        enclosed copy of this Letter Agreement whereupon this will constitute the
        agreement of the parties with respect to the subject matter referenced herein.
        

       

      

       

      

      Very
        truly yours,

      

      VENTIV
        HEALTH, INC.

      

      

      By:__/s/
        Eran Broshy________________________   

      Eran
        Broshy

      CEO 

      

      

      

      Accepted
        and agreed to by:_/s/ Terrell Herring_____________________  Dated:______________             Terrell
        HerringTH's EA 05/09/07

    May
      7,
      2007

    

    Terrell
      Herring

    

    
      	 	
              Re:

            	
              Amendment
                to Stock Option Agreement(s) /Restricted Stock Award
                Agreement(s)
                and Employment Agreement

            

    

    

    Dear
      Terry:

    

    As
      you
      know, inVentiv Health, Inc. (the “Corporation”) has previously granted to you
      certain options (the “Options”) to purchase shares of common stock, $0.001 par
      value, of the Corporation. As of the date hereof, you are the owner of the
      following Options:

    

    
      	
              Option
                Number

            	
              Option
                Grant Date

            	
              Number
                of Option Shares

            
	
              00001770

            	
              12/10/2003

            	
              20,000

            
	
              00001895

            	
              9/23/2004

            	
              150,000

            
	
              00002202

            	
              1/17/2006

            	
              33,750

            
	
              00002586

            	
              1/22/2007

            	
              31,211

            

    

    

    Additionally,
      you have been awarded restricted shares of common stock, par value $.001 per
      share, of the Corporation (the “Restricted Stock”).
      As of
      this date hereof, you have been awarded the following Restricted Stock
      grants:

    

    
      	
              Award
                Number

            	
              Award
                Date

            	
              Number
                of Restricted Shares

            
	
              00002027

            	
              3/9/2005

            	
              4,000

            
	
              00002197

            	
              1/17/2006

            	
              8,438

            
	
              00002603*

            	
              1/22/2007

            	
              14,282

            
	
              00002625

            	
              1/22/2007

            	
              14,282

            

    

    

    *
      denotes
      a performance based grant.

    

    We
      hereby
      confirm the following:

    

    1.
      Section 1(c) of each option agreement/notice of grant relating to the Options
      listed above is hereby amended to provide that such Options and the shares
      of
      common stock subject thereto shall immediately vest in the event that your
      employment with the Corporation is terminated by the Corporation “Without Cause”
(as defined in Section 5(d) of the Employment Agreement dated April
      8,
      2002 between
      you and the Corporation (the “Employment Agreement”)) within six (6) months
      following a “Change of Control” (as defined in Section 5(f) of the Employment
      Agreement) of the Corporation. 

    

    2.
      Section 3 of each of the notices of grant relating to award numbers 00002027,
      00002197, and 00002625 is hereby amended to provide that the shares of
      Restricted Stock subject thereto shall immediately vest in the event that your
      employment with the Corporation is terminated by the Corporation “Without Cause”
within six (6) months following a “Change of Control” (in each case as so
      defined).

    

    3.
      Section 3 of the notice of grant relating to award number 00002603 is hereby
      amended to provide that in the event your employment with the Corporation is
      terminated by the Corporation “Without Cause” upon or after six (6) months
      following a “Change of Control” (in each case as so defined), a number of shares
      of Restricted Stock subject thereto equal to the Target Number (as defined
      in
      such notice of grant) shall immediately vest.

    

    
      	2.  	
              Continuing
                Effectiveness of Stock Option Agreements/ Restricted Stock
                Awards

            

    

    

    Except
      as
      modified herein, the above-referenced award documentation remains in full force
      and effect.

    

    
      	3.  	
              Amendment
                to Employment
                Agreement

            

    

    

    

    This
      letter shall serve to amend the April 8, 2002 Employment Agreement between
      you
      and the Company, as amended January 1, 2004, June 15, 2004, October 18, 2004
      and
      January 23, 2006 (the "Employment Agreement") in accordance with the following,
      which amendment shall be effective as of the date hereof, in the case of
      paragraphs a. and f. below, and as of July 1, 2007:

    

    
      	a.  	
              Duties.

            

    

     

    The
      first
      sentence of Section 2 of the Employment Agreement is hereby amended to read
      as
      follows:

     

    The
      Executive shall serve as the Chief Operating Officer of the Company and
      President & CEO of the Company's inVentiv Commercial Services division and
      shall perform such duties, functions and responsibilities as are associated
      with
      and incident to that position and as the Company may, from time to time, require
      of him. The Executive shall assume responsibility as the Chief Operating Officer
      of the Company no later than July 1, 2007.

     

    
      	b.  	
              Base
                Salary.
                

            

    

     

    The
      first
      sentence of Section 3(a) of the Employment Agreement is hereby amended to read
      as follows:

     

    The
      Company shall pay the Executive a base salary at an annual rate of $425,000
      payable at such times and in accordance with the Company's customary payroll
      practices as they may be adopted or modified from time to time. 

     

    
      	c.  	
              Bonus.
                

            

    

     

    The
      last
      sentence of Section 3 (c) of
      the
      Employment Agreement is hereby amended to read as follows:

    

     

    If
      the
      Executive remains employed through December 31, 2007, the Executive will be
      guaranteed a minimum bonus payout of $150,000 for 2007. 

     

    
      	d.  	
              Termination
                Without Cause or for Good
                Reason.

            

    

     

    Section
      6
      (c) of
      the
      Employment Agreement is hereby amended to read as follows:

     

    (i)
      If
      the Executive's employment hereunder is terminated by the Company Without Cause
      pursuant to Section 5(a)(iv) above or For Good Reason pursuant to Section 5
      (a)(v) the Company shall award the Executive severance benefits, subject to
      the
      terms and conditions of this Agreement and of The Ventiv Health, Inc. Severance
      Benefit Plan, if applicable as follows: a lump sum payment of fifty two (52)
      weeks of the Executive’s base pay, minus such deductions as may be required by
      law or reasonably requested by the Executive to be paid out immediately. If
      Executive has not secured a new position with a competitive company in the
      Pharma Services arena within 52-weeks from his termination, the Executive will
      receive up to an additional twenty six (26) weeks of Executive’s base pay
      commencing on the first anniversary of the effective date of the termination
      as
      long as he has not been employed by, or otherwise rendered services, directly
      or
      indirectly, in any capacity to, a company in the pharma services arena prior
      to
      such first anniversary and continues to be refrained from being so employed
      or
      otherwise rendering such services during such additional 26-week period. The
      additional twenty six (26) weeks of Executive’s base pay will be paid bi-weekly,
      reduced by such deductions as may be required by law or reasonably requested
      by
      the Executive. In order to be eligible to receive any severance payment pursuant
      to this paragraph 6(c)(i), the Executive must sign, prior to receiving such
      severance payment, a valid release and waiver of all claims against the Company
      relating to the executive’s employment or the termination thereof, in a format
      to be determined by the Company. No payment shall be made hereunder until at
      least eight (8) days following the execution and delivery by the Executive
      of
      the valid release and waiver.

     

    (ii)
      If
      the Executive, on the one hand and either the Chief Executive Officer or the
      President of the Company, on the other, agree in writing that the Executive's
      employment shall terminate pursuant to this Section 6(c)(ii), then (x) the
      Executive acknowledges that such termination shall be deemed a resignation
      without Good Reason and agrees that the Company shall not have any obligation
      to
      pay severance as described in Section 6(c)(i), (y) such resignation shall be
      effective on the later of (I) July 1, 2008 and (II) the expiration of the notice
      period provided for in Section 6(e) (measured from the date of such written
      agreement) and (z) the Company shall award the Executive termination benefits,
      subject to the terms and conditions of this Agreement and of the inVentiv
      Health, Inc. Severance Benefit Plan, if applicable, as follows: a lump sum
      payment of Six (6) months of the Executive’s base pay, minus such deductions as
      may be required by law or reasonably requested by the Executive to be paid
      out
      immediately. In order to be eligible to receive any termination benefit pursuant
      to this paragraph 6(c)(ii), the Executive must sign, prior to receiving such
      termination benefit, a valid release and waiver of all claims against the
      Company relating to the executive’s employment or the termination thereof, in a
      format to be determined by the Company. No payment shall be made hereunder
      until
      at least eight (8) days following the execution and delivery by the Executive
      of
      the valid release and waiver.

     

    
      	e.  	
              Notice
                of Resignation

            

    

     

    The
      following is added as Section 6 (e) of
      the
      Employment Agreement:

     

    e.
      The
      Executive shall give the Company one (1) months notice prior to any resignation
      with the exception of resignation pursuant to Section 6(c)(ii). If the Executive
      resigns pursuant to Section 6(c)(ii), the Executive will give the company two
      (2) Months notice of the effective date of the resignation.

     

    f.
      Continuing Effectiveness
      of Employment Agreement

     

    Except
      as
      modified herein, the Employment Agreement dated April 8, 2002, shall remain
      in
      full force and effect in accordance with their respective terms. 

     

    

    Very
      truly yours,

    

    INVENTIV
      HEALTH, INC.

    

    

    By:
      _/s/
      Eran Broshy_________________   

    Eran
      Broshy

    Chairman
      & CEO 

    

    

    Accepted
      and agreed to by:__/s/
      Terrell Herring_________  Dated:______________         Terrell
      Herring

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]